Dr. Krishna K. Pachipala, MD

Dr. Pachipala practices at American Oncology Partners PA in Asheville, North Carolina.

Dr. Pachipala's NPI, 1386609188, was assigned on April 18, 2006. Dr. Pachipala graduated from Kurnool Medical College in 1989. Dr. Pachipala holds Texas license M6815.

Dr. Pachipala's primary practice is American Oncology Partners PA, at 551 Brevard Rd, Asheville, NC 28806 in Buncombe County. The practice phone is (614) 383-6000.

Dr. Pachipala's primary practice is American Oncology Partners PA in Asheville, North Carolina. Dr. Pachipala is also affiliated with Memorial Hermann Greater Heights Hospital. The medical group on file is Zangmeister Cancer Center. Dmand AI also links Dr. Pachipala to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pachipala practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Pachipala's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Pachipala is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Pachipala's licenses on file in 2 states: Texas and Pennsylvania.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances and lung cancer among the conditions Dr. Pachipala treats.

CMS data shows 26,226 Medicare services from Dr. Pachipala across 30 procedure codes in 2024, for 405 Medicare patients. Medicare paid $227,773 for them.

CMS counts 405 Medicare patients who saw Dr. Pachipala in 2024. The largest group is 65 to 74, with 194 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pachipala's median patient age at 73, with 50% women.

In 2024, Dr. Pachipala wrote 1,058 Medicare Part D claims for 227 patients. 61% of them were for generic drugs. CMS names the drug for 797 of them, across 26 drugs with 11 or more claims each, at $2,472,819 in total drug cost. In 2023, CMS named 1,215 claims across 36 drugs.

Dr. Pachipala accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Pachipala in 2024. Dr. Pachipala's most frequent co-authors are Julie Elaine Bauman, MD, MPH and Sana Dole Karam, MD.

Dmand AI links Dr. Pachipala to 8 clinical trials, 3 of them phase 1/2 studies. 1 is still active or recruiting. Conditions studied include Carcinoma, Bronchogenic, Breast Neoplasms and Carcinoma, Non-Small-Cell Lung. G1 Therapeutics, Inc. sponsors the most, 3.

CMS Open Payments shows 902 general payments to Dr. Pachipala from 76 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 42% of the total. Novartis Pharmaceuticals Corporation paid the most, $6,963.

Dr. Pachipala graduated from Kurnool Medical College in 1989.

Dr. Pachipala is in network with 21 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.